
Esophageal and Gastrosophageal Junction (GEJ) Cancer 2025 UPDATE
Two Onc Docs
00:00
Systemic Therapy for Advanced or Metastatic Disease
Hosts outline workup (HER2, PD-L1, MMR, CLDN18.2, NGS) and state chemotherapy backbones and when to add HER2, immunotherapy, or claudin-targeted agents.
Play episode from 10:45
Transcript


